Niagen Bioscience
Charlotte Zhou currently serves as the Chief Financial Officer at ChromaDex, a bioscience company focused on healthy aging and the study of nicotinamide adenine dinucleotide (NAD+). Prior to joining ChromaDex in June 2023, Charlotte held various roles at Mattel, Inc. from October 2013 to May 2023, including Director of Corporate Financial Planning & Analysis and Senior Manager of both Corporate Financial Planning & Analysis and Investor Relations. Notable achievements at Mattel include leading the 2021 Annual Planning process and enhancing alignment on growth objectives for key brands. Additionally, Charlotte’s experience includes working as a Results Analyst at Capital Guardian Trust Company, servicing approximately 65 institutional clients in performance measurement and market analysis. Charlotte Zhou holds a Bachelor's Degree in Economics from Sun Yat-sen University - Lingnan College and an MBA from USC Marshall School of Business.
This person is not in any offices